KDM1A and breast cancer: To determine how LSD1 inhibition with phenelzine globally impacts gene expression programs, CD8+ cells isolated from liquid biopsies from TNBC and HER2− breast cancer patients were treated with phenelzine and subjected to RNA-seq.